Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-02-17
1988-09-27
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548120, 548121, C07D29312, A61K 3141
Patent
active
047742526
ABSTRACT:
The present invention relates to new benzisoselenazolonyl derivatives of the general formula (I) ##STR1## and processes for the treatment of rheumatic diseases.
REFERENCES:
patent: 4352799 (1982-10-01), Renson et al.
patent: 4418069 (1983-11-01), Welter et al.
patent: 4454068 (1984-06-01), Welter et al.
patent: 4550168 (1985-10-01), Welter et al.
S. Leyck, E. Etschenberg, U. Hadding, J. Winkelmann, Agents and Actions, 13, pp. 437-438 (1983).
W. Kraus and P. Oehm, Das Deutsche Gesundheitswesen, 1979, 34(37), 1713-1718, and 1979, 34(37), 1769-1773.
W. R. Gaythwaite, J. Kenyon and H. Phillips, J. Chem. Soc. (1928), 2280.
Dereu Norbert
Etschenberg Eugen
Huther Andrea
Lambert Christian
Welter Andre
A. Nattermann & Cie GmbH
Gerstl Robert
LandOfFree
Benzisoselenazolonyl derivatives and processes for the treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzisoselenazolonyl derivatives and processes for the treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzisoselenazolonyl derivatives and processes for the treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2398157